Improving Surgical Outcomes Through IBD Patient Optimization

Surgery is a common treatment option for IBD patients and as healthcare professionals, we need to recognize strategies that will improve surgical outcomes. In this webinar, you will acquire practical takeaways from expert advanced practice providers on factors that optimize IBD patients including patient education, nutrition considerations, medication management, recovery protocols, and patient follow-up.

Live Meeting

Information

August 29, 2022

08:00 PM - 09:00 PM EDT

Virtual
Improving Surgical Outcomes Through IBD Patient Optimization

ssarode@crohnscolitisfoundation.org

ENROLL

Details

Comments

Overview
Learning objectives:
1. Recognize the importance of the patient-provider relationship and patient education for improved surgical outcomes
2. Discuss strategies to optimize patients prior to surgery in order to improve surgical outcomes
3. Discuss strategies to optimize patients post-surgery in order to improve surgical outcomes
Speakers:
Michele Rubin, APN, CNS, CGRN
Associate Director IBD Center; Surgery
The University of Chicago Medicine
Abigail J Meyers, PA-C
Inflammatory Bowel Disease Clinic
Mayo Clinic Rochester
This activity is generously supported, in part, by a sponsorship from Takeda Pharmaceuticals U.S.A., Inc. Additional support is provided through the Foundation's annual giving program and donors.

Facebook Comments

Details

Comments

Overview
Learning objectives:
1. Recognize the importance of the patient-provider relationship and patient education for improved surgical outcomes
2. Discuss strategies to optimize patients prior to surgery in order to improve surgical outcomes
3. Discuss strategies to optimize patients post-surgery in order to improve surgical outcomes
Speakers:
Michele Rubin, APN, CNS, CGRN
Associate Director IBD Center; Surgery
The University of Chicago Medicine
Abigail J Meyers, PA-C
Inflammatory Bowel Disease Clinic
Mayo Clinic Rochester
This activity is generously supported, in part, by a sponsorship from Takeda Pharmaceuticals U.S.A., Inc. Additional support is provided through the Foundation's annual giving program and donors.